Back to results
US 9,173,865 B2Granted
Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol
AssigneeZafgen, Inc.
InventorThomas E. Hughes
Life of this patent
Estimating the term…
Abstract
The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g, a MetAP-2 inhibitor.
Claims5
A method for treating obesity or for reducing body weight in a human patient in need thereof, comprising subcutaneously administering to the patient, once or twice weekly, a dose of a formulation comprising about 0.5 mg/m2 to about 1.5 mg/m2, based on the patient's actual or calculated surface area, of the free base of 6-O-(4-dimethylaminoethoxy)cinnamoyl fumagillol.
Dependencies are inferred from the claim text.